How multiplex PCR is revolutionizing DNA testing

• Multiplex polymerase chain reaction (PCR) enables simultaneous detection of multiple targets within a single reaction, improving efficiency and reducing operational workload 
• Multiplex testing supports detection of several pathogens or genetic variants at once, strengthening disease diagnostics, genetic analysis, and high-throughput research
• Advances in digital PCR, artificial intelligence (AI)–driven assay design, and microfluidic technologies continue to expand the performance and future potential of multiplex PCR

Multiplex polymerase chain reaction (PCR) has become one of the most practical advances to emerge from the original PCR framework — an innovation that in itself was a turning point in molecular biology. Conventional PCR enabled laboratories to amplify defined, single DNA sequences with precision. Multiplex PCR extends that capability by allowing several target genes or regions of interest to be amplified in a single reaction.¹ For teams managing high sample volumes or complex diagnostic panels, this shift delivers clear advantages.

By extracting more information per run while conserving valuable samples, multiplex PCR reduces hands-on steps, reagent use, and time to result.² These efficiencies make it a dependable tool in infectious disease testing, genetic analysis, and research, where accuracy and operational performance carry equal weight.

Multiplex PCR is an advanced molecular technique that builds on traditional PCR by allowing the simultaneous detection of multiple targets in a single reaction. 

Unlike conventional PCR, which amplifies one DNA sequence at a time, multiplex PCR can amplify several genes or regions of interest from the same sample, conserving material and streamlining workflows. This capability is especially valuable in infectious disease testing, genetic analysis, and research, where multiplex PCR improves diagnostic speed, enhances accuracy, and increases efficiency by providing more information from each run.^1,2

Multiplex PCR is central to modern DNA testing, supporting clinical decision-making and research-driven discovery. Its ability to detect multiple pathogens, variants, or genetic markers simultaneously makes it invaluable in infectious disease diagnostics, genetic testing, oncology, and public health surveillance.³

Multiplex PCR accelerates infectious disease diagnosis, where rapid, accurate results directly influence patient care. In 2019, an estimated 13.7 million deaths were associated with infectious diseases worldwide, underscoring the need for timely diagnosis and targeted treatment.⁴ Traditional culture-based methods remain reliable but can take up to 72 hours, potentially delaying critical interventions for conditions such as sepsis and infections in immunocompromised patients. Multiplex PCR compresses this timeline to 3–⁠4 hours, detecting multiple pathogens and resistance markers within a single run.⁵

Faster results support earlier, targeted antimicrobial therapy and reduce unnecessary broad-spectrum antibiotic use — an essential component of antimicrobial stewardship. Multiplex panels are particularly useful in settings where polymicrobial infections are common or where rapid differentiation among viral and bacterial causes is needed.5 During respiratory outbreaks, multiplex panels can identify influenza, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and respiratory syncytial virus (RSV) from one sample, enabling faster triage and treatment.^6,7

Multiplex PCR also improves sexually transmitted infection (STI) testing by simultaneously detecting Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis — common pathogens causing STIs — from a single urine sample.^8,9

Early diagnosis and treatment are essential to prevent or minimize serious complications and reduce transmission, making rapid, consolidated testing particularly valuable in clinical practice. Streamlined multiplex testing reduces repeat visits, improves follow-up, and expands access to care.⁸

Multiplex PCR enables simultaneous identification of multiple loci for inherited diseases and cancer. In families with a history of inherited cardiac conditions, multiplex PCR has been used to screen multiple known pathogenic mutations in a single reaction, providing an efficient approach to genetic risk assessment.10 Multiplex testing has also been applied in the analysis of large deletion patterns in the DMD gene among patients with Duchenne and Becker muscular dystrophy, supporting personalized medicine.11

In oncology, multiplex PCR facilitates sensitive, high-throughput mutation profiling from limited or circulating DNA. For metastatic breast cancer, multiplex digital PCR assays detect multiple PIK3CA hotspot mutations from plasma samples, enabling non-invasive molecular monitoring.¹² Similarly, in colorectal cancer, a proof-of-concept method combining multiplex PCR with surface-enhanced Raman scattering (PCR/SERS) has demonstrated simultaneous detection of multiple circulating tumor DNA (ctDNA) mutations, supporting real-time assessment of tumor burden and therapeutic response.¹³ These approaches illustrate the expanding potential of multiplex technology in minimally invasive cancer diagnostics and disease monitoring.

Multiplex PCR underpins high-throughput surveillance and research, screening many targets in parallel from complex or limited samples. For instance, recent studies used wastewater-based multiplex PCR amplicon sequencing to track community transmission of SARS-CoV-2 lineages in China and Canada.^14,15 The approach successfully deconvoluted mixed viral populations, revealing variant spread across dormitory sewage pools and demonstrating its effectiveness in public-health surveillance.

Another example comes from plant-pathogen diagnostics: researchers applied a high-multiplex PCR panel (499 primer pairs) followed by high-throughput sequencing (HTS) to test over 100 prime and stone fruit tree samples for 27 viruses and 7 viroids. This “HiPlex” workflow delivered sensitive, reproducible detection across dozens of virus and viroid species in hundreds of samples — a scale unattainable with single-target PCR or traditional methods.¹⁶

Multiplex testing offers laboratories operational and diagnostic advantages by combining speed, efficiency, and comprehensive testing in one workflow. Key benefits include:

• Faster turnaround times (TAT) — multiplex PCR delivers results in 3–⁠4 hours, compared with up to three days for traditional culture. Rapid respiratory infection panels can reduce intensive care unit (ICU) stays by an average of two days⁵
• Cost-effectiveness — testing multiple targets in a single reaction reduces reagent consumption and labor. For example, multiplex STI and other infectious disease panels lower per-patient testing costs by consolidating assays that would otherwise require separate runs8
• Smaller sample volumes — one multiplex reaction can detect multiple pathogens or genetic markers from minimal material, preserving scarce specimens such as neonatal blood or biopsy tissue17
• Greater throughput — multiplex testing increases the number of targets tested per run without proportional increase in labor or time. By consolidating multiple assays into a single reaction, labs can process more samples or screen for more pathogens or genetic markers in the same amount of hands-on time^1,2

Despite its efficiency and versatility, multiplex PCR presents technical considerations that laboratories need to address to ensure reliable performance:1^8-⁠20

• Primer design complexity — designing multiple primers to work efficiently in a single reaction requires careful optimization to avoid competition or preferential amplification. Advanced software tools and validated primer panels can streamline assay design and reduce trial-and-error iterations
• Cross-reactivity and specificity — simultaneous amplification of multiple targets can occasionally produce non-specific signals. Careful selection of primers, probes, and optimized reaction conditions minimizes cross-reactivity and maintains diagnostic accuracy
• Assay flexibility limitations — adding new targets to an existing multiplex panel can require re-validation to ensure all targets are reliably detected. Modular assay design and periodic re-optimization allow labs to expand panels while preserving performance

By proactively addressing these considerations, laboratories can harness multiplex PCR’s speed, efficiency, and high-throughput advantages without compromising accuracy or reliability.

Multiplex PCR is entering a new phase as it converges with digital PCR, artificial intelligence (AI)-driven design, and microfluidics. Digital PCR increases sensitivity and enables absolute quantification of rare targets. Recent multiplex digital PCR assays can simultaneously quantify multiple microRNAs, showing the method’s growing versatility.²¹

Meanwhile, microfluidic “lab-on-a-chip” platforms now support multiplex real-time PCR in automated, compact cartridges, reducing sample and reagent use, cutting hands-on time, and accelerating turnaround.²² Data-driven optimization, including machine-learning analysis of amplification curves, further enhances multiplex panel design and target detection, pointing to more robust, high-throughput workflows.²³

Together, these trends point toward more accessible, scalable, and flexible multiplex testing, enabling comprehensive molecular profiling in both centralized labs and decentralized settings.

Multiplex PCR continues to redefine DNA testing by enabling simultaneous detection of multiple targets with speed, accuracy, and efficiency. From infectious disease panels to genetic and cancer diagnostics, multiplex testing streamlines workflows, conserves samples, and supports high-throughput analysis — directly improving patient care and laboratory performance.

Explore featured articles or contact us to learn how multiplex PCR can advance your lab’s innovation and diagnostic capabilities.